Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18] FLT vs [F-18] FDG PET for Treatment Evaluation in Head and Neck Cancer
NCT00894101Phase 3Withdrawn
- Sponsor
- University of California, Irvine
- Start
- May 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorothymidine F-18 in head and neck cancer (HNC), lung cancer, sponsored by University of California, Irvine. Planned start May 2009; status: withdrawn.
02
Drugs
fluorothymidine F-18
03
Conditions
head and neck cancer (HNC)lung cancer
Beyond the preview
Go deeper on NCT00894101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894101.